Company logo

MGNX - MacroGenics, Inc.

NASDAQ -> Healthcare -> Biotechnology
Rockville, United States
Type: Equity

MGNX price evolution
MGNX
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $100.96 $89.9 $108.76 $224.26
Short term investments $128.85 $166.53 $131.59 $17.39
Net receivables $10.37 $25.31 $6.41 $36.16
Inventory $1.22 $1.07 $1.44 $1.41
Total current assets $251.34 $291.32 $254.68 $288.94
Long term investments
Property, plant & equipment $45.69 $47.27 $49.59 $53.18
Goodwill & intangible assets
Total noncurrent assets $47.08 $48.65 $50.98 $54.55
Total investments $128.85 $166.53 $131.59 $17.39
Total assets $298.42 $339.97 $305.65 $343.5
Current liabilities
Accounts payable $6.44 $3.3 $3.79 $3.76
Deferred revenue $80.89 $82.84 $68.21 $67.25
Short long term debt $3.77 $3.93 $4.16 $4.42
Total current liabilities $56.11 $51.29 $45.16 $45.61
Long term debt $30.2 $30.18 $30.16 $30.13
Total noncurrent liabilities $89.7 $94.7 $88.95 $188.62
Total debt $33.97 $34.11 $34.32 $34.55
Total liabilities $145.81 $145.99 $134.11 $234.23
Shareholders' equity
Retained earnings -$1102.75 -$1056.68 -$1074.23 -$1131.7
Other shareholder equity -$0.01 -$0.03 -$0.07 $0.01
Total shareholder equity $152.61 $193.98 $171.54 $109.27
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $100.96 $108.88 $123.47 $181.13
Short term investments $128.85 $45.46 $120.15 $91.4
Net receivables $10.37 $56.22 $10.39 $23.08
Inventory $1.22 $1.45 $4.39
Total current assets $251.34 $222.18 $279.56 $312.59
Long term investments
Property, plant & equipment $45.69 $56.91 $37.68 $42.23
Goodwill & intangible assets
Total noncurrent assets $47.08 $58.29 $55.69 $66.15
Total investments $128.85 $45.46 $120.15 $91.4
Total assets $298.42 $280.47 $335.25 $378.74
Current liabilities
Accounts payable $6.44 $4.9 $15.5 $8.03
Deferred revenue $80.89 $69.47 $20.65 $11.38
Short long term debt $3.77 $4.73 $4.68 $3.99
Total current liabilities $56.11 $48.61 $74.58 $50.67
Long term debt $30.2 $30.11 $20.79 $25.26
Total noncurrent liabilities $89.7 $89.84 $21.05 $32.19
Total debt $33.97 $34.83 $25.47 $29.25
Total liabilities $145.81 $138.46 $95.63 $82.86
Shareholders' equity
Retained earnings -$1102.75 -$1093.69 -$973.94 -$771.82
Other shareholder equity -$0.01 -$0.01 -$0.06 -$0.01
Total shareholder equity $152.61 $142.01 $239.62 $295.88
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $10.72 $10.4 $13.14 $24.5
Cost of revenue $0.16 $3.36 $1.18 $3.52
Gross Profit $10.56 $7.04 $11.96 $20.97
Operating activities
Research & development $47.35 $30.13 $43.23 $45.87
Selling, general & administrative $12.56 $12.41 $13.69 $13.53
Total operating expenses $59.91 $42.54 $56.92 $59.4
Operating income -$49.35 -$35.5 -$44.96 -$38.43
Income from continuing operations
EBIT -$46.07 $17.55 $58.24 -$37.35
Income tax expense
Interest expense $0.77 $0.66
Net income
Net income -$46.07 $17.55 $57.47 -$38.01
Income (for common shares) -$46.07 $17.55 $57.47 -$38.01
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $58.75 $151.94 $77.45 $104.88
Cost of revenue $8.22 $7.38 $2.65
Gross Profit $50.53 $144.56 $74.8 $104.88
Operating activities
Research & development $166.58 $207.03 $214.58 $193.2
Selling, general & administrative $52.19 $58.95 $63.01 $42.74
Total operating expenses $218.77 $265.98 $277.59 $235.94
Operating income -$168.24 -$121.42 -$202.79 -$131.06
Income from continuing operations
EBIT -$7.63 -$119.76 -$202.12 -$129.74
Income tax expense
Interest expense $1.43
Net income
Net income -$9.06 -$119.76 -$202.12 -$129.74
Income (for common shares) -$9.06 -$119.76 -$202.12 -$129.74
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$46.07 $17.55 $57.47 -$38.01
Operating activities
Depreciation $2.69 $2.82 $3.71 $3.92
Business acquisitions & disposals
Stock-based compensation $4.36 $4.79 $4.39 $4.83
Total cash flows from operations -$28.04 -$35.25 -$2.09 -$12.83
Investing activities
Capital expenditures -$0.62 -$0.49 -$0.23 -$0.36
Investments $39.44 -$33.04 -$113.24 $28.45
Total cash flows from investing $38.82 -$33.52 -$113.48 $28.09
Financing activities
Dividends paid
Sale and purchase of stock $0.27 $0.05 $0.22 $0.62
Net borrowings -$0 $50 -$0.16
Total cash flows from financing $0.27 $49.91 $0.06 $100.12
Effect of exchange rate
Change in cash and equivalents $11.06 -$18.86 -$115.51 $115.38
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$9.06 -$119.76 -$202.12 -$129.74
Operating activities
Depreciation $13.13 $11.87 $11.26 $11.96
Business acquisitions & disposals
Stock-based compensation $18.37 $20.44 $23.13 $20.68
Total cash flows from operations -$78.2 -$86.96 -$143.83 -$111.9
Investing activities
Capital expenditures -$1.7 -$3.62 -$6.2 -$5.91
Investments -$78.38 $74.34 -$30.41 -$1.88
Total cash flows from investing -$80.08 $70.72 -$36.61 -$7.79
Financing activities
Dividends paid
Sale and purchase of stock $1.17 $1.66 $122.78 $174.34
Net borrowings $149.5
Total cash flows from financing $150.36 $1.66 $122.78 $174.34
Effect of exchange rate
Change in cash and equivalents -$7.93 -$14.59 -$57.66 $54.66
Fundamentals
Market cap $928.58M
Enterprise value $861.59M
Shares outstanding 62.07M
Revenue $58.75M
EBITDA $5.51M
EBIT -$7.63M
Net Income -$9.06M
Revenue Q/Q -85.33%
Revenue Y/Y -61.33%
P/E ratio -102.51
EV/Sales 14.67
EV/EBITDA 156.48
EV/EBIT -112.95
P/S ratio 15.81
P/B ratio 6.08
Book/Share 2.46
Cash/Share 1.63
EPS -$0.15
ROA -2.81%
ROE -5.77%
Debt/Equity 0.96
Net debt/EBITDA 8.15
Current ratio 4.48
Quick ratio 4.46